Ebsteins anomaly of the tricuspid valve MRI: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 14: Line 14:
====Advantages of MRI====
====Advantages of MRI====
* It can be used in cases where [[echocardiographic]] results are inconclusive.
* It can be used in cases where [[echocardiographic]] results are inconclusive.
* Helps in measuring [[heart]] volumes, blood flow and ventricular wall thickness.
* Helps in measuring [[heart]] [[Volume|volumes]], [[blood flow]] and [[ventricular]] wall thickness.
* The magnetic resonance angiography helps in better visualization of heart vasculature and measuring the size the pulmonary arteries
* The [[magnetic resonance angiography]] helps in better visualization of [[heart]] [[vasculature]] and measuring the size the [[pulmonary arteries]]
* Phase velocity mapping helps in measuring the ratio of pulmonary to systemic blood flow (Qp:Qs).  
* Phase [[velocity]] mapping helps in measuring the ratio of [[pulmonary]] to [[systemic]] [[blood flow]] (Qp:Qs).


====Disadvantages of MRI====
====Disadvantages of MRI====
*For successful MRI procedure breath holding is required, which is sometimes difficult to achieve with small kids.
*For successful [[MRI]] procedure [[breath]] holding is required, which is sometimes difficult to achieve with small kids.
*Some patients may become claustrophobic.
*Some [[patients]] may become [[Claustrophobia|claustrophobic.]]
*Due to the above, the procedure is sometimes done under general anesthesia in children.
*Due to the above, the procedure is sometimes done under [[general anesthesia]] in [[children]].
*There may be limited expertise to interpret the MRI as well.
*There may be limited expertise to interpret the [[MRI]] as well.


==ACC/AHA 2018 Guidelines for the Diagnostic recommendations of Adults With Ebstein Anomaly(DO NOT EDIT)<ref name="pmid30121239">{{cite journal |vauthors=Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF |title=2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |journal=J. Am. Coll. Cardiol. |volume=73 |issue=12 |pages=e81–e192 |date=April 2019 |pmid=30121239 |doi=10.1016/j.jacc.2018.08.1029 |url=}}</ref><ref name="StoutDaniels2019">{{cite journal|last1=Stout|first1=Karen K.|last2=Daniels|first2=Curt J.|last3=Aboulhosn|first3=Jamil A.|last4=Bozkurt|first4=Biykem|last5=Broberg|first5=Craig S.|last6=Colman|first6=Jack M.|last7=Crumb|first7=Stephen R.|last8=Dearani|first8=Joseph A.|last9=Fuller|first9=Stephanie|last10=Gurvitz|first10=Michelle|last11=Khairy|first11=Paul|last12=Landzberg|first12=Michael J.|last13=Saidi|first13=Arwa|last14=Valente|first14=Anne Marie|last15=Van Hare|first15=George F.|title=2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease|journal=Journal of the American College of Cardiology|volume=73|issue=12|year=2019|pages=e81–e192|issn=07351097|doi=10.1016/j.jacc.2018.08.1029}}</ref>==
==ACC/AHA 2018 Guidelines for the Diagnostic recommendations of Adults With Ebstein Anomaly(DO NOT EDIT)<ref name="pmid30121239">{{cite journal |vauthors=Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF |title=2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |journal=J. Am. Coll. Cardiol. |volume=73 |issue=12 |pages=e81–e192 |date=April 2019 |pmid=30121239 |doi=10.1016/j.jacc.2018.08.1029 |url=}}</ref><ref name="StoutDaniels2019">{{cite journal|last1=Stout|first1=Karen K.|last2=Daniels|first2=Curt J.|last3=Aboulhosn|first3=Jamil A.|last4=Bozkurt|first4=Biykem|last5=Broberg|first5=Craig S.|last6=Colman|first6=Jack M.|last7=Crumb|first7=Stephen R.|last8=Dearani|first8=Joseph A.|last9=Fuller|first9=Stephanie|last10=Gurvitz|first10=Michelle|last11=Khairy|first11=Paul|last12=Landzberg|first12=Michael J.|last13=Saidi|first13=Arwa|last14=Valente|first14=Anne Marie|last15=Van Hare|first15=George F.|title=2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease|journal=Journal of the American College of Cardiology|volume=73|issue=12|year=2019|pages=e81–e192|issn=07351097|doi=10.1016/j.jacc.2018.08.1029}}</ref>==

Revision as of 14:51, 16 February 2020

Ebsteins anomaly of the tricuspid valve Microchapters

Home

Patient Information

Overview

Historical Perpective

Classification

Pathophysiology

Causes

Differentiating Ebstein's Anomaly from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography

CT

MRI

Other Imaging Findings

Other diagnostic studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Ebsteins anomaly of the tricuspid valve MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ebsteins anomaly of the tricuspid valve MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ebsteins anomaly of the tricuspid valve MRI

CDC on Ebsteins anomaly of the tricuspid valve MRI

Ebsteins anomaly of the tricuspid valve MRI in the news

Blogs on Ebsteins anomaly of the tricuspid valve MRI

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Ebsteins anomaly of the tricuspid valve MRI

Ebsteins anomaly of the tricuspid valve Microchapters

Home

Patient Information

Overview

Historical Perpective

Classification

Pathophysiology

Causes

Differentiating Ebstein's Anomaly from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography

CT

MRI

Other Imaging Findings

Other diagnostic studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Ebsteins anomaly of the tricuspid valve MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ebsteins anomaly of the tricuspid valve MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ebsteins anomaly of the tricuspid valve MRI

CDC on Ebsteins anomaly of the tricuspid valve MRI

Ebsteins anomaly of the tricuspid valve MRI in the news

Blogs on Ebsteins anomaly of the tricuspid valve MRI

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Ebsteins anomaly of the tricuspid valve MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]}; Keri Shafer, M.D. [4] Priyamvada Singh, MBBS [[5]] Assistant Editor-In-Chief: Kristin Feeney, B.S. [[6]]

Overview

Magnetic resonance imaging can be helpful as a diagnostic tool in conditions where the echocardiographic findings are inconclusive.[1]

Magnetic resonance imaging

Magnetic resonance imaging (MRI) can be used as a diagnostic modality in the evaluation of the patient who is suspected to have Ebstein's anomaly if the echocardiogram is inconclusive.

Advantages of MRI

Disadvantages of MRI

ACC/AHA 2018 Guidelines for the Diagnostic recommendations of Adults With Ebstein Anomaly(DO NOT EDIT)[2][3]

Class IIa
1.. In adults with Ebstein anomaly, CMR(cardiac magnetic resonance imaging) can be useful to determine anatomy, RV dimensions, and systolic function. (Level of Evidence: B)

References

  1. Eustace S, Kruskal JB, Hartnell GG (1994). "Ebstein's anomaly presenting in adulthood: the role of cine magnetic resonance imaging in diagnosis". Clinical Radiology. 49 (10): 690–2. PMID 7955830. Unknown parameter |month= ignored (help); |access-date= requires |url= (help)
  2. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM, Crumb SR, Dearani JA, Fuller S, Gurvitz M, Khairy P, Landzberg MJ, Saidi A, Valente AM, Van Hare GF (April 2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". J. Am. Coll. Cardiol. 73 (12): e81–e192. doi:10.1016/j.jacc.2018.08.1029. PMID 30121239.
  3. Stout, Karen K.; Daniels, Curt J.; Aboulhosn, Jamil A.; Bozkurt, Biykem; Broberg, Craig S.; Colman, Jack M.; Crumb, Stephen R.; Dearani, Joseph A.; Fuller, Stephanie; Gurvitz, Michelle; Khairy, Paul; Landzberg, Michael J.; Saidi, Arwa; Valente, Anne Marie; Van Hare, George F. (2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease". Journal of the American College of Cardiology. 73 (12): e81–e192. doi:10.1016/j.jacc.2018.08.1029. ISSN 0735-1097.

Template:WH

Template:WS